Design and in vitro pharmacology of a selective γ-aminobutyric acid(C) receptor antagonist

D. Ragozzino, R. M. Woodward, Y. Murata, F. Eusebi, L. E. Overman, R. Miledi

Research output: Contribution to journalArticle

148 Citations (Scopus)

Abstract

In mammals, receptors for the inhibitory neurotransmitter γ- aminobutyric acid (GABA) are divided into three pharmacological classes, which are denoted GABA(A), GABA(B), and GABA(C). GABA(C) receptors are defined by their insensitivity to the GABA(A) receptor antagonist bicuculline and the GABA(B) receptor agonist (-)-baclofen. GABA(C) receptors probably are a heterogeneous group of proteins. The most extensively studied mammalian GABA(C) receptors are those found in neurons of the outer retina. These receptors are GABA-gated Cl- channels comprised of ρ subunits, of which there are two subtypes. The physiological functions served by GABA(C) receptors are largely unknown; to determine the functions, it would be useful to have GABA(C)-selective ligands. In a previous study, we found that isoguvacine, a GABA(A)-selective agonist, and 3-aminopropyl- (methyl)phosphinic acid (3-APMPA), a GABA(B)-selective agonist, show affinity for retinal GABA(C) receptors. In particular, 3-APMPA is an antagonist with low micromolar potency (K(b) ≃ 1 μM). Here, we report the synthesis and pharmacological characterization of (1,2,5,6-tetrahydropyridine-4- yl)methylphosphinic acid (TPMPA), a hybrid of isoguvacine and 3-APMPA designed to retain affinity for GABA(C) receptors but not to interact with GABA(A) or GABA(B) receptors. Electrical assays show that TPMPA is a competitive antagonist of cloned human ρ1 GABA(C) receptors expressed in Xenopus laevis oocytes {K(b) ≃ 2 μM). TPM PA is > 100-fold weaker as an inhibitor of rat brain GABA(A) receptors expressed in oocytes (K(b) ≃ 320 μM) and has only weak agonist activity on GABA(B) receptors assayed in rat hippocampal slices (EC50 = 500 μM). TPMPA should be a useful pharmacological probe with which to investigate GABA(C) receptor function in the outer retina and in any other areas of the nervous system in which these types of receptor are present.

Original languageEnglish
Pages (from-to)1024-1030
Number of pages7
JournalMolecular Pharmacology
Volume50
Issue number4
Publication statusPublished - Oct 1996

Fingerprint

Aminobutyrates
Pharmacology
gamma-Aminobutyric Acid
GABA-B Receptor Agonists
GABA-B Receptors
Oocytes
Retina
GABA-A Receptor Agonists
GABA-A Receptor Antagonists
Baclofen
Neurotransmitter Receptor
GABA Receptors
Bicuculline
In Vitro Techniques
GABA-C receptor
Xenopus laevis
GABA-A Receptors
Nervous System
Mammals
Ligands

ASJC Scopus subject areas

  • Pharmacology

Cite this

Ragozzino, D., Woodward, R. M., Murata, Y., Eusebi, F., Overman, L. E., & Miledi, R. (1996). Design and in vitro pharmacology of a selective γ-aminobutyric acid(C) receptor antagonist. Molecular Pharmacology, 50(4), 1024-1030.

Design and in vitro pharmacology of a selective γ-aminobutyric acid(C) receptor antagonist. / Ragozzino, D.; Woodward, R. M.; Murata, Y.; Eusebi, F.; Overman, L. E.; Miledi, R.

In: Molecular Pharmacology, Vol. 50, No. 4, 10.1996, p. 1024-1030.

Research output: Contribution to journalArticle

Ragozzino, D, Woodward, RM, Murata, Y, Eusebi, F, Overman, LE & Miledi, R 1996, 'Design and in vitro pharmacology of a selective γ-aminobutyric acid(C) receptor antagonist', Molecular Pharmacology, vol. 50, no. 4, pp. 1024-1030.
Ragozzino D, Woodward RM, Murata Y, Eusebi F, Overman LE, Miledi R. Design and in vitro pharmacology of a selective γ-aminobutyric acid(C) receptor antagonist. Molecular Pharmacology. 1996 Oct;50(4):1024-1030.
Ragozzino, D. ; Woodward, R. M. ; Murata, Y. ; Eusebi, F. ; Overman, L. E. ; Miledi, R. / Design and in vitro pharmacology of a selective γ-aminobutyric acid(C) receptor antagonist. In: Molecular Pharmacology. 1996 ; Vol. 50, No. 4. pp. 1024-1030.
@article{b87025b8f43a4f51a4f286d95e7ff9c6,
title = "Design and in vitro pharmacology of a selective γ-aminobutyric acid(C) receptor antagonist",
abstract = "In mammals, receptors for the inhibitory neurotransmitter γ- aminobutyric acid (GABA) are divided into three pharmacological classes, which are denoted GABA(A), GABA(B), and GABA(C). GABA(C) receptors are defined by their insensitivity to the GABA(A) receptor antagonist bicuculline and the GABA(B) receptor agonist (-)-baclofen. GABA(C) receptors probably are a heterogeneous group of proteins. The most extensively studied mammalian GABA(C) receptors are those found in neurons of the outer retina. These receptors are GABA-gated Cl- channels comprised of ρ subunits, of which there are two subtypes. The physiological functions served by GABA(C) receptors are largely unknown; to determine the functions, it would be useful to have GABA(C)-selective ligands. In a previous study, we found that isoguvacine, a GABA(A)-selective agonist, and 3-aminopropyl- (methyl)phosphinic acid (3-APMPA), a GABA(B)-selective agonist, show affinity for retinal GABA(C) receptors. In particular, 3-APMPA is an antagonist with low micromolar potency (K(b) ≃ 1 μM). Here, we report the synthesis and pharmacological characterization of (1,2,5,6-tetrahydropyridine-4- yl)methylphosphinic acid (TPMPA), a hybrid of isoguvacine and 3-APMPA designed to retain affinity for GABA(C) receptors but not to interact with GABA(A) or GABA(B) receptors. Electrical assays show that TPMPA is a competitive antagonist of cloned human ρ1 GABA(C) receptors expressed in Xenopus laevis oocytes {K(b) ≃ 2 μM). TPM PA is > 100-fold weaker as an inhibitor of rat brain GABA(A) receptors expressed in oocytes (K(b) ≃ 320 μM) and has only weak agonist activity on GABA(B) receptors assayed in rat hippocampal slices (EC50 = 500 μM). TPMPA should be a useful pharmacological probe with which to investigate GABA(C) receptor function in the outer retina and in any other areas of the nervous system in which these types of receptor are present.",
author = "D. Ragozzino and Woodward, {R. M.} and Y. Murata and F. Eusebi and Overman, {L. E.} and R. Miledi",
year = "1996",
month = "10",
language = "English",
volume = "50",
pages = "1024--1030",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "4",

}

TY - JOUR

T1 - Design and in vitro pharmacology of a selective γ-aminobutyric acid(C) receptor antagonist

AU - Ragozzino, D.

AU - Woodward, R. M.

AU - Murata, Y.

AU - Eusebi, F.

AU - Overman, L. E.

AU - Miledi, R.

PY - 1996/10

Y1 - 1996/10

N2 - In mammals, receptors for the inhibitory neurotransmitter γ- aminobutyric acid (GABA) are divided into three pharmacological classes, which are denoted GABA(A), GABA(B), and GABA(C). GABA(C) receptors are defined by their insensitivity to the GABA(A) receptor antagonist bicuculline and the GABA(B) receptor agonist (-)-baclofen. GABA(C) receptors probably are a heterogeneous group of proteins. The most extensively studied mammalian GABA(C) receptors are those found in neurons of the outer retina. These receptors are GABA-gated Cl- channels comprised of ρ subunits, of which there are two subtypes. The physiological functions served by GABA(C) receptors are largely unknown; to determine the functions, it would be useful to have GABA(C)-selective ligands. In a previous study, we found that isoguvacine, a GABA(A)-selective agonist, and 3-aminopropyl- (methyl)phosphinic acid (3-APMPA), a GABA(B)-selective agonist, show affinity for retinal GABA(C) receptors. In particular, 3-APMPA is an antagonist with low micromolar potency (K(b) ≃ 1 μM). Here, we report the synthesis and pharmacological characterization of (1,2,5,6-tetrahydropyridine-4- yl)methylphosphinic acid (TPMPA), a hybrid of isoguvacine and 3-APMPA designed to retain affinity for GABA(C) receptors but not to interact with GABA(A) or GABA(B) receptors. Electrical assays show that TPMPA is a competitive antagonist of cloned human ρ1 GABA(C) receptors expressed in Xenopus laevis oocytes {K(b) ≃ 2 μM). TPM PA is > 100-fold weaker as an inhibitor of rat brain GABA(A) receptors expressed in oocytes (K(b) ≃ 320 μM) and has only weak agonist activity on GABA(B) receptors assayed in rat hippocampal slices (EC50 = 500 μM). TPMPA should be a useful pharmacological probe with which to investigate GABA(C) receptor function in the outer retina and in any other areas of the nervous system in which these types of receptor are present.

AB - In mammals, receptors for the inhibitory neurotransmitter γ- aminobutyric acid (GABA) are divided into three pharmacological classes, which are denoted GABA(A), GABA(B), and GABA(C). GABA(C) receptors are defined by their insensitivity to the GABA(A) receptor antagonist bicuculline and the GABA(B) receptor agonist (-)-baclofen. GABA(C) receptors probably are a heterogeneous group of proteins. The most extensively studied mammalian GABA(C) receptors are those found in neurons of the outer retina. These receptors are GABA-gated Cl- channels comprised of ρ subunits, of which there are two subtypes. The physiological functions served by GABA(C) receptors are largely unknown; to determine the functions, it would be useful to have GABA(C)-selective ligands. In a previous study, we found that isoguvacine, a GABA(A)-selective agonist, and 3-aminopropyl- (methyl)phosphinic acid (3-APMPA), a GABA(B)-selective agonist, show affinity for retinal GABA(C) receptors. In particular, 3-APMPA is an antagonist with low micromolar potency (K(b) ≃ 1 μM). Here, we report the synthesis and pharmacological characterization of (1,2,5,6-tetrahydropyridine-4- yl)methylphosphinic acid (TPMPA), a hybrid of isoguvacine and 3-APMPA designed to retain affinity for GABA(C) receptors but not to interact with GABA(A) or GABA(B) receptors. Electrical assays show that TPMPA is a competitive antagonist of cloned human ρ1 GABA(C) receptors expressed in Xenopus laevis oocytes {K(b) ≃ 2 μM). TPM PA is > 100-fold weaker as an inhibitor of rat brain GABA(A) receptors expressed in oocytes (K(b) ≃ 320 μM) and has only weak agonist activity on GABA(B) receptors assayed in rat hippocampal slices (EC50 = 500 μM). TPMPA should be a useful pharmacological probe with which to investigate GABA(C) receptor function in the outer retina and in any other areas of the nervous system in which these types of receptor are present.

UR - http://www.scopus.com/inward/record.url?scp=0029859986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029859986&partnerID=8YFLogxK

M3 - Article

C2 - 8863850

AN - SCOPUS:0029859986

VL - 50

SP - 1024

EP - 1030

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 4

ER -